AI-native pharma company, bringing new treatments to patients faster and more efficiently.

Joined November 2014
88 Photos and videos
Pinned Tweet
The world has more promising discovered drug candidates than ever. The problem is developing them. We built Formation Bio to fix that, using AI to develop drugs faster and with a higher likelihood of success. Thank you @amyfeldman and @Forbes telling the story of our mission, and our vision for the future of pharma. forbes.com/sites/amyfeldman/…
2
8
56
36,834
Looking forward to hearing @BenjamineYLiu speak on advancing late-stage assets at MIT CEO next week, hosted by @LongwoodLeaders.
1
5
125
Five months after in-licensing BLKR201 from Lynk Pharmaceuticals, Formation Bio has dosed the first participant in a Phase 1 trial. BLKR201 is an investigational CNS-penetrant TYK2 inhibitor, and its CNS exposure and selectivity may unlock disease areas existing TYK2 therapies haven't reached. Data readout expected early 2027. Learn more: prnewswire.com/news-releases…
2
8
336
We were proud to host 150 runners from the biotech and AI communities across our Boston and NYC Tech Week events, and it was a privilege to connect so many people with a shared passion for building companies that can help bring new medicines to patients faster. Thank you to everyone who ran with us! Take a peek into this week’s run in NYC.
1
3
236
In just one year, $7.7B was spent on clinical trials that were ultimately terminated. Better trial prediction could change that. Delphi, our multi-agent clinical trial prediction system, surfaces probability of success predictions backed by extensive evidence and reasoning. Read more about Delphi here: formation.bio/blog/delphi-cl…
1
4
289
Last week, we gathered the AI & Biotech community up and at ‘em early in Boston for a 5K run followed by breakfast. New York is next – join us for a 5K run, breakfast at our office, and conversations with our teams who are building AI for drug development. Link to register: partiful.com/e/FJXCHsTzgGQQQ…
1
2
7
374
Raising the standard of care for patients means delivering treatments that are safer, more effective, or better suited to specific patient needs than what's already available. Here’s how we built a flexible intelligence framework to structure clinical data, visualize efficacy-safety tradeoffs, and define success at scale: formation.bio/blog/where-dru…
2
4
161
90 non-engineers. One week. A working AI app each. At Formation Bio, building with AI is a baseline expectation for everyone. Ops, clinicians, HR, marketing – everyone. Real tools, shipped, tied to real work. We’re hiring across many teams. If you’d like to join us, open roles are linked in the comments.
AI-native is a term a lot of companies use, but few can show you what it really looks like. Last week, the entire company shipped software: scientists, ops, clinicians, HR, marketing... many for the first time. Building on the data platform and tech stack our engineers have spent years developing, everyone was shipping practical tools in days. AI is moving fast. Raising the floor on what every team can build, not just engineers, is how @formationbio is creating and leading the pharma company of the future. Link to our open roles in comments.
1
1
8
1,155
Applying validated biology to underexplored disease areas has produced some of medicine's most important therapies, but what's hard is doing it systematically – exhaustively following every evidence chain across every potential mechanism-indication pair. We call this approach Known in New, and in our latest blog, we explore how Formation Bio is building the capability to do it at scale: formation.bio/blog/known-in-…
1
5
230
Formation Bio retweeted
AI-native is a term a lot of companies use, but few can show you what it really looks like. Last week, the entire company shipped software: scientists, ops, clinicians, HR, marketing... many for the first time. Building on the data platform and tech stack our engineers have spent years developing, everyone was shipping practical tools in days. AI is moving fast. Raising the floor on what every team can build, not just engineers, is how @formationbio is creating and leading the pharma company of the future. Link to our open roles in comments.
1
1
1
1,410
Formation Bio retweeted
Apr 29
we just added a bunch of new roles to our careers page, including in tech/marketing: formation.bio/careers if you're a builder passionate about bio acceleration, DMs are open!
1
5
18
1,872
The best conversations happen with your running shoes on. We're hosting @Techweek_ events in both Boston and New York this year, and we'd love for you to join us. We'll kick off with a 5k group run along the river (all paces welcome), then head back to our office for breakfast. 📍 Boston — May 27 along the Charles River: partiful.com/e/FJXCHsTzgGQQQ… 📍 New York — June 2 along the Hudson River Greenway: partiful.com/e/Dy7rUqrhVPwyY… More info and links to register above. #BOSTechWeek #NYTechWeek
2
4
344
Last week, Formation Bio CTO @dan_neil joined the @AWS Life Sciences Symposium reception panel alongside leaders from @Lux_Capital, @abbvie, and @AstraZeneca. With the conversation focused on innovation, Dan spoke about how one of the biggest bottlenecks facing drug development is actually organizational, and fixing this starts with how institutional knowledge is built and kept. At Formation Bio, we build so that every program makes the next one smarter. Read more about Dan's thinking here: formation.bio/blog/building-…
2
5
238
Great to see our CDO Gavin Corcoran in action on Monday at the Chief Medical Officer 360º Summit, by @FierceBiotech, exploring how we use AI to enhance clinical development. Gavin spoke about how real impact comes from AI systems that let you reimagine entire workflows, not just augment individual people within an old workflow. Learn more about our approach: formation.bio/blog
2
4
432
Our VP of Talent, Emily Gransky, joined The Biohub Podcast last week on AI-native talent strategy: from MCP-powered interview analysis to agentic recruiting workflows. Full conversation and open roles linked below.
1
5
5
525
Last week, we hosted the Princeton Entrepreneurship Club for a Q&A with our CEO @BenjamineYLiu to discuss our founding story, approaching problem-solving with an entrepreneurial mindset, and what it takes to build and scale a company in the AI age.
1
3
244
Next week, our team will be at @PHUSE_Global US Connect in Austin to share insights on bridging the gap between AI demos and production-ready tools in clinical development, and the open-source innovations shaping the future of clinical data. Learn more here: cdisc.org/events/education/e…
183